Paper3000618
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
Wang D and 2 others. Cell, 1985. Cited by 1,129 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Papers, record 3000618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000618
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Viral | Major topic |
| Cell Transformation, Viral | Major topic |
| Herpesvirus 4, Human | Major topic |
| Viral Matrix Proteins | Major topic |
| Animals | |
| Cell Division | |
| Cell Line | |
| Cloning, Molecular | |
| Fibroblasts | |
| Lymphocytes | |
| Mice | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Neoplasms, Experimental | |
| Rats |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 17281 | NCI NIH HHS | United States | R01CA017281 | PubMed and NIH | NIH RePORTER |
| CA 19264 | NCI NIH HHS | United States | P01CA019264 | PubMed and NIH | NIH RePORTER |
| GM 07281 | NIGMS NIH HHS | United States | T32GM007281 | PubMed and NIH | NIH RePORTER |
Cited by457
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42075858 | Resveratrol Induces Proteasomal Degradation of PTPN1 to Enhance Cisplatin Sensitivity in Epstein-Barr Virus-Associated Malignancies. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075858 | PubMed |
| 41959378 | CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959378 | PubMed |
| 41890102 | A CRISPR-Cas9 screen Reveals STEEP1 as a Key Host Dependency Factor for Epstein-Barr Virus Latent Membrane Protein 1 Trafficking and Signaling. | bioRxiv | 2026 | https://conductscience.org/library/papers/41890102 | PubMed |
| 41587214 | Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41587214 | PubMed |
| 41311374 | Epstein-Barr virus LMP1 promotes tumorigenesis in a murine epithelial tumor model. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/41311374 | PubMed |
| 40950096 | Epstein-Barr Virus Latent Membrane Protein 1 targets cIAP1, cIAP2 and TRAF2 for Proteasomal Degradation to Activate the Non-canonical NF-κB Pathway. | bioRxiv | 2025 | https://conductscience.org/library/papers/40950096 | PubMed |
| 40685972 | EBV Latency Programs: Molecular and Epigenetic Regulation and Its Role in Disease Pathogenesis. | J Med Virol | 2025 | https://conductscience.org/library/papers/40685972 | PubMed |
| 40573426 | The Use of Intrinsic Disorder and Phosphorylation by Oncogenic Viral Proteins to Dysregulate the Host Cell Cycle Through Interaction with pRb. | Viruses | 2025 | https://conductscience.org/library/papers/40573426 | PubMed |
| 40534857 | T cell-mediated immune surveillance conferred by latent Epstein-Barr virus genes suppresses a broad spectrum of tumor formation through NKG2D-NKG2DL interactions. | Front Immunol | 2025 | https://conductscience.org/library/papers/40534857 | PubMed |
| 40367275 | Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40367275 | PubMed |
| 40047459 | Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma. | Int J Cancer | 2025 | https://conductscience.org/library/papers/40047459 | PubMed |
| 39948602 | Detection of the 30-bp deletion and protein expression of Epstein-Barr virus latent membrane protein 1 in extranodal NK/T cell lymphoma and its clinicopathological significance. | Diagn Pathol | 2025 | https://conductscience.org/library/papers/39948602 | PubMed |
| 39843898 | Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment. | Nat Commun | 2025 | https://conductscience.org/library/papers/39843898 | PubMed |
| 39513855 | 3D-Q-FISH/Telomere/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma. | Cells | 2024 | https://conductscience.org/library/papers/39513855 | PubMed |
| 39001390 | Serum NF-κB in Epstein-Barr Virus-Related Oropharyngeal Carcinoma Diagnostic Usability. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39001390 | PubMed |
| 38675906 | Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective. | Viruses | 2024 | https://conductscience.org/library/papers/38675906 | PubMed |
| 38195569 | Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex. | Nat Commun | 2024 | https://conductscience.org/library/papers/38195569 | PubMed |
| 38136637 | Role of Virus-Induced EGFR Trafficking in Proviral Functions. | Biomolecules | 2023 | https://conductscience.org/library/papers/38136637 | PubMed |
| 38004636 | Establishment of Epstein-Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1. | Microorganisms | 2023 | https://conductscience.org/library/papers/38004636 | PubMed |
| 37493769 | Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma. | Braz J Med Biol Res | 2023 | https://conductscience.org/library/papers/37493769 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PDLIM7 | 9260 | PubTator's text mining | https://conductscience.org/library/genes/9260 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3000618
GET https://conductscience.org/api/papers/v1/3000618/cited_by?page=2